MedPath

Defect in human NK cells, HPV infection and development of cancer

Not Applicable
Conditions
Health Condition 1: null- Cervical cancer cases,HPV infected women with healthy cervix
Registration Number
CTRI/2017/09/009621
Lead Sponsor
ICMR National Institute for Research in Reproductive Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Study subjects (from TMH):

Group I.Women with established cervical cancer

Control subjects (from KEM Hospital):

Group II. HPV infected women having normal cervix (PV examination and Pap smear results)

Group III. Women without any genital infection and having normal cervix (PV examination and Pap smear results)

Exclusion Criteria

Women with any other cancer will be excluded from the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The study will highlight, <br/ ><br>why NK cells fail to recognize the tumor cells that become cancerous. <br/ ><br>Timepoint: <br/ ><br>Study period 3 years
Secondary Outcome Measures
NameTimeMethod
Comparing the polymorphisms/expression seen in NK cell receptors may highlight, which genes/genotypes or polymorphisms are associated with susceptibility to HPV infection, persistent infection and further with development of cervical cancer. In future, identification of such susceptible or protective host factors/genes may be useful for the benefit of the case management.Timepoint: Study period 3 years
© Copyright 2025. All Rights Reserved by MedPath